Recent Updates
Recently added Catalysts
VKTX

Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2019 on February 26, 2020

Key Takeaway: Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2019 on February 26, 2020

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+53%
120-day peak, hindsight
Typical move
13.6%
average across 5 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
VK2735
Phase 3 · Weight Loss

Full Press Release Details

Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2019 on February 26, 2020.
Last updated: Feb 19, 2020